Cargando…
Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
Understanding the antigenic signatures of all human coronaviruses (HCoVs) Spike (S) proteins is imperative for pan-HCoV epitopes identification and broadly effective vaccine development. To depict the currently elusive antigenic signatures of α-HCoVs S proteins, we isolated a panel of antibodies aga...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636267/ https://www.ncbi.nlm.nih.gov/pubmed/36333470 http://dx.doi.org/10.1038/s42003-022-04160-8 |
_version_ | 1784824907560910848 |
---|---|
author | Xiang, Jiangchao Su, Jie Lan, Qiaoshuai Zhao, Wenwen Zhou, Yu Xu, Youwei Niu, Jun Xia, Shuai Qi, Qilian Sidhu, Sachdev Lu, Lu Miersch, Shane Yang, Bei |
author_facet | Xiang, Jiangchao Su, Jie Lan, Qiaoshuai Zhao, Wenwen Zhou, Yu Xu, Youwei Niu, Jun Xia, Shuai Qi, Qilian Sidhu, Sachdev Lu, Lu Miersch, Shane Yang, Bei |
author_sort | Xiang, Jiangchao |
collection | PubMed |
description | Understanding the antigenic signatures of all human coronaviruses (HCoVs) Spike (S) proteins is imperative for pan-HCoV epitopes identification and broadly effective vaccine development. To depict the currently elusive antigenic signatures of α-HCoVs S proteins, we isolated a panel of antibodies against the HCoV-229E S protein and characterized their epitopes and neutralizing potential. We found that the N-terminal domain of HCoV-229E S protein is antigenically dominant wherein an antigenic supersite is present and appears conserved in HCoV-NL63, which holds potential to serve as a pan-α-HCoVs epitope. In the receptor binding domain, a neutralizing epitope is captured in the end distal to the receptor binding site, reminiscent of the locations of the SARS-CoV-2 RBD cryptic epitopes. We also identified a neutralizing antibody that recognizes the connector domain, thus representing the first S2-directed neutralizing antibody against α-HCoVs. The unraveled HCoVs S proteins antigenic similarities and variances among genera highlight the challenges faced by pan-HCoV vaccine design while supporting the feasibility of broadly effective vaccine development against a subset of HCoVs. |
format | Online Article Text |
id | pubmed-9636267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96362672022-11-06 Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein Xiang, Jiangchao Su, Jie Lan, Qiaoshuai Zhao, Wenwen Zhou, Yu Xu, Youwei Niu, Jun Xia, Shuai Qi, Qilian Sidhu, Sachdev Lu, Lu Miersch, Shane Yang, Bei Commun Biol Article Understanding the antigenic signatures of all human coronaviruses (HCoVs) Spike (S) proteins is imperative for pan-HCoV epitopes identification and broadly effective vaccine development. To depict the currently elusive antigenic signatures of α-HCoVs S proteins, we isolated a panel of antibodies against the HCoV-229E S protein and characterized their epitopes and neutralizing potential. We found that the N-terminal domain of HCoV-229E S protein is antigenically dominant wherein an antigenic supersite is present and appears conserved in HCoV-NL63, which holds potential to serve as a pan-α-HCoVs epitope. In the receptor binding domain, a neutralizing epitope is captured in the end distal to the receptor binding site, reminiscent of the locations of the SARS-CoV-2 RBD cryptic epitopes. We also identified a neutralizing antibody that recognizes the connector domain, thus representing the first S2-directed neutralizing antibody against α-HCoVs. The unraveled HCoVs S proteins antigenic similarities and variances among genera highlight the challenges faced by pan-HCoV vaccine design while supporting the feasibility of broadly effective vaccine development against a subset of HCoVs. Nature Publishing Group UK 2022-11-04 /pmc/articles/PMC9636267/ /pubmed/36333470 http://dx.doi.org/10.1038/s42003-022-04160-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Xiang, Jiangchao Su, Jie Lan, Qiaoshuai Zhao, Wenwen Zhou, Yu Xu, Youwei Niu, Jun Xia, Shuai Qi, Qilian Sidhu, Sachdev Lu, Lu Miersch, Shane Yang, Bei Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein |
title | Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein |
title_full | Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein |
title_fullStr | Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein |
title_full_unstemmed | Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein |
title_short | Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein |
title_sort | antigenic mapping reveals sites of vulnerability on α-hcov spike protein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636267/ https://www.ncbi.nlm.nih.gov/pubmed/36333470 http://dx.doi.org/10.1038/s42003-022-04160-8 |
work_keys_str_mv | AT xiangjiangchao antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT sujie antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT lanqiaoshuai antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT zhaowenwen antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT zhouyu antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT xuyouwei antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT niujun antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT xiashuai antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT qiqilian antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT sidhusachdev antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT lulu antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT mierschshane antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein AT yangbei antigenicmappingrevealssitesofvulnerabilityonahcovspikeprotein |